Affirm Holdings (NASDAQ: AFRM ) is a fast-growing player in the Buy Now, Pay Later market and is nearing a crucial inflection point in its business, which is the achievement of GAAP operating profitability in the near term. Further, Affirm may be aAnalyst’s Disclosure:I/we have a beneficial long position in the shares of AFRM, UPST, SOFI either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other ...

目 录 一、审计报告 二、审计报告附送 三、审计报告附件 南京黄埔大酒店有限公司财务报表附注 南京黄埔大酒店有限公司 审计报告书 中兴华会计师事务所(特殊普通合伙) ZHONGXINGHUA CERTIFIED PUBLIC ACCOUNTANTS LLP 地址：北京市丰台区丽泽路 20 号丽泽 SOHO Ｂ座 20 层 邮编：100037 电话：(010) 51423818 传真：(010) 51423816 南京黄埔大酒店有限公司 财务报表附注 （除特别说明外，金额单位为人民币元） 一、公司基本情况 南京黄埔大酒店有限公司（以下简称"公司"或"本公司"）成立于 2002 年 9 月 12 日，统一社会信 用代码：913201027423628876；注册资本：人民币 1,384.8759 万元；法定代表人：杨飞；注册地址： 南京市玄武区黄埔路 2 号。公司母公司为南京旅游集团有限责任公司，最终控制方为南京市人民 政府国有资产监督管理委员会。 本公司属住宿和餐饮行业，经营范围主要包括：住宿服务、餐饮服务及其他配套服务等。 本财务报表业经本公司董事会于2025年6月18日决议批准报出。 二、财务报表的编制基础 ...

中信建投证券股份有限公司 关于南京商贸旅游股份有限公司 本次方案调整不构成重组方案重大调整的核查意见 "公司"）召开第十届二十五次董事会，审议通过了《关于〈南京商贸旅游股份 有限公司发行股份及支付现金购买资产并募集配套资金暨关联交易预案〉及其摘 要的议案》等议案，并披露了《南京商旅发行股份及支付现金购买资产并募集配 套资金暨关联交易预案》及相关公告，南京商旅拟通过发行股份及支付现金的方 式购买南京旅游集团有限责任公司（以下简称"旅游集团"）持有的南京黄埔大 酒店有限公司（以下简称"黄埔酒店"）100%股权、南京商厦股份有限公司（以 下简称"南京商厦"）持有的南京南商商业运营管理有限责任公司（以下简称"南 商运营"）49%股权并募集配套资金（以下简称"本次重组"、"本次交易"）。 整公司发行股份及支付现金购买资产并募集配套资金暨关联交易方案且本次方 案调整构成重大调整的议案》 《关于 <南京商贸旅游股份有限公司发行股份及支付> 现金购买资产并募集配套资金暨关联交易报告书（草案）>及其摘要的议案》等 有关议案，对本次重组方案进行了调整，拟不再收购南京商厦持有的南商运营 持有的黄埔酒店 100%股权并募集配套资金。 ...

INDIANAPOLIS, June 25, 2025 (GLOBE NEWSWIRE) -- Kite Realty Group (NYSE: KRG) announced today the release of its annual Corporate Responsibility Report, which provides a comprehensive overview of the Company’s strategy and initiatives regarding corporate responsibility practices and policies. The report also details progress, measurements, and case studies around the Company’s goals and related operations. “KRG’s corporate responsibility initiatives reflect our inherent dedication to advancing sustainabilit ...

Financial results FQ3 2025 Safe harbor statement During the course of this meeting, we may make projections or other forward-looking statements regarding market demand and supply, market and pricing trends and drivers, the impact of technologies such as AI, the impact of our reorganization, cost reductions, our manufacturing projects and related investments, expected product volume production, our market position, expected product announcements, capabilities of our future products and technologies, future e ...

Core Viewpoint - Reviva Pharmaceuticals Holdings, Inc. plans to offer shares of its common stock and warrants in a public offering to fund research and development activities and for general corporate purposes [1][2]. Company Overview - Reviva is a late-stage biopharmaceutical company focused on developing therapies for unmet medical needs in central nervous system (CNS), inflammatory, and cardiometabolic diseases [5]. - The company's pipeline includes two drug candidates, brilaroxazine (RP5063) and RP1208, both of which are new chemical entities discovered in-house and have been granted composition of matter patents in multiple regions [5]. Offering Details - The offering will be conducted under an effective shelf registration statement on Form S-3, filed with the U.S. Securities and Exchange Commission (SEC) [3]. - A.G.P./Alliance Global Partners is acting as the sole placement agent for the offering [2].

Management Comments "Net revenues of $1.63 billion for the second quarter reflect a resilient full-service investment banking and capital markets business against a backdrop of significant uncertainty related to U.S. policy and geopolitical events which meaningfully slowed activity levels for the first two months of the quarter. In May, some clarity came to the economy and markets, which began to restore investor confidence, and we experienced a noticeable increase in momentum. Despite the difficult first t ...

中信证券股份有限公司 关于 中国建设银行股份有限公司 向特定对象发行 A 股股票 之上市保荐书 保荐人（联席主承销商） 住所：广东省深圳市福田区中心三路 8 号 卓越时代广场（二期）北座 二〇二五年六月 中国建设银行股份有限公司 向特定对象发行 A 股股票上市保荐书 声 明 中信证券股份有限公司（以下简称"中信证券""保荐人"或"本保荐人"） 接受中国建设银行股份有限公司（以下简称"建设银行""发行人"或"公司"） 的委托，担任建设银行本次向特定对象发行 A 股股票（以下简称"本次发行"） 的保荐人，为本次发行出具上市保荐书。 保荐人及指定的保荐代表人根据《中华人民共和国公司法》《中华人民共和 国证券法》 《上市公司证券发行注册管理办法》 《证券发行上市保荐业务管理办法》 （以下简称《保荐办法》）等有关法律、法规和中国证券监督管理委员会、上海 证券交易所的有关规定，诚实守信，勤勉尽责，严格按照依法制订的业务规则、 行业执业规范和道德准则出具上市保荐书，并保证所出具文件真实、准确、完整。 本上市保荐书所有简称释义，如无特别说明，均与《中国建设银行股份有限 公司向特定对象发行 A 股股票募集说明书》中相同。 中国 ...

Core Viewpoint - Allete's shares have entered oversold territory with a Relative Strength Index (RSI) reading of 29.7, indicating potential buying opportunities as heavy selling may be exhausting [1][2][3] Group 1: Stock Performance - Allete shares traded as low as $63.555, with a current trading price of $63.65, reflecting a decrease of approximately 0.3% on the day [1][3] - The 52-week range for Allete shares is between $61.51 (low) and $66.40 (high) [3] Group 2: Technical Indicators - The average RSI for the energy stocks universe is 51.1, while WTI Crude Oil has an RSI of 47.5, and Henry Hub Natural Gas is at 41.4 [2] - The 3-2-1 Crack Spread RSI is currently at 45.6, indicating a relatively stronger position compared to Allete's RSI [2]

Company Overview - Techcon, part of OK International and Dover, is a leader in precision fluid dispensing technologies, recently launching a new line of Side-by-Side (SBS) Dispensing Cartridges for various industries including electronics, industrial, medical device, and automotive [1][5] - OK International, a global manufacturer of bench tools and equipment, focuses on operational excellence and innovation, with core brands including Metcal and Techcon [6] - Dover Corporation is a diversified global manufacturer with annual revenue exceeding $7 billion, operating across five segments and employing approximately 24,000 people [7] Product Launch - Techcon's SBS Cartridge is designed for precise metering and dispensing of 2-component (2K) adhesives and sealants, available in sizes of 50 ml and 200 ml, with mixing ratios of 1:1, 2:1, and 10:1 [2][3] - The SBS Cartridges are made of polypropylene, ensuring compatibility with a wide range of chemicals, and are designed to work with standard cartridge guns [3] Market Application - The new SBS line is aimed at industries that regularly utilize dual cartridge dispensing for two-part materials, enhancing the ability to package, mix, and dispense 2K materials efficiently [3]